We had a great Workshop with Thibault Keverrec on Poroid Neoplasms. The recording will be released on 10/22.
We had a great Workshop with Thibault Keverrec on Poroid Neoplasms. The recording will be released on 10/22.
We had a great 2 hour-long Workshop on Keratoacanthoma with Dr. Richard Carr on 9/17th. It was a really great event that had impact on my practice. The recording is scheduled to be available on Sunday, 9/20th. I highly recommend it.
All SENIOR MEMBERS have access to the 2023 Dermpedia CME Course! Membership includes access to course which after 3 years loose their formal CME accreditation.
I am reaching out today to share a bit about our core philosophy and to introduce a program designed specifically to help you take the next step in your dermatopathology education.
There is a massive amount of free medical education online right now, particularly on social media. While that accessibility is fantastic, "free" often comes with a hidden price. On those platforms, you aren't the student—you are the product being sold to advertisers. You are forced to navigate intrusive ads, chaotic feeds, and platforms that were ultimately designed to distract you, not educate you.
I built Dermpedia to be completely different. We provide a premium, dedicated, and ad-free environment combining the interactive community of a modern professional society with the high-definition streaming quality of platforms like Netflix.
However, building and maintaining this level of independent digital infrastructure without selling ads or user data means that Dermpedia cannot be entirely free.
At the same time, we are deeply committed to our mission: world-class dermatopathology education must be accessible to everyone, regardless of where they live or their career stage. That is why I am incredibly proud to highlight the Dermpedia Tuition Assistance Program.
If the standard cost of a full membership is a barrier to your continued learning, we want to help. We offer significantly discounted (up to 90%)—premium memberships for:
Trainees: Current residents and fellows worldwide.
Global Practitioners: Colleagues practicing in developing nations (based on World Bank economic classifications).
If you fall into either of these categories, please do not let cost be a barrier to advancing your diagnostic skills.
I would like to announce the launch of Dermpedia Academy, a branch of Dermpedia chaired by Dr. Jerad Gartner, dedicated to education of residents, fellow and general surgical pathologists interested in or forced to signout dermpath. We are also launching Trainee/International Tuition Assistance Program. The goal of this program is to adjust the Dermpedia fees to reflect the purchasing power of physicians in different countries and stages of their career.
Check out this 🆓 lecture on thinking in terms of probability about management of melanocytic lesions. You will love it https://dermpedia.org/programs/decoding-dermpath-for-pcps-thinking-in-bets-melanocytic-lesions1bed20
I haven't been able to join the live consultation sessions for a while. The link isn't working. How are things with you guys?Dermpedia Appps are available to download for both Android and Apple. These are a reader Apps, like Netflix, which will allow you to view content, download videos, create playlists, see the schedule of live events and access them from the Calendar, communicate with Dermpedia members, get notifications and announcements, and more. Account management (purchasing membership or courses) requires access via a browser. Download your Dermpedia App now.
I just wanted to let you know that there is a new process for accessing Dermpedia Live Events. You will have to login in to the website (or create a new account). For free events during the first login, you will see CLAIM BUNDLE-click on it. Follow instructions on the screen. Give me feedback, good or bad. We appreciate your patience as we fine tune Dermpedia.
Not sure if this is the right place for this, however, for the low-grade apocrine adenocarcinoma consult case, I thought of secretory carcinoma. Probably doesn’t matter that much, as treatment would be the same. Still, I wanted to share the thought and wonder what your take is on this consideration.